GSK1838705A, with the CAS number 1116235-97-2, is a chemical compound that has been investigated primarily for its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective inhibitor of certain protein kinases, which play crucial roles in various cellular processes, including cell growth, differentiation, and metabolism. The compound has been studied in the context of various diseases, particularly cancer, due to its ability to modulate signaling pathways that are often dysregulated in tumorigenesis. GSK1838705A exhibits specific binding affinity to its target kinases, which contributes to its efficacy and selectivity. In terms of physical properties, detailed solubility, stability, and pharmacokinetic profiles are typically assessed during drug development, although specific values may vary based on formulation and testing conditions. Overall, GSK1838705A represents a promising candidate in the field of medicinal chemistry, particularly in the development of targeted therapies.

GSK1838705A

1116235-97-2: GSK1838705A, with the CAS number 1116235-97-2, is a chemical compound that has been investigated primarily for its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective inhibitor of certain protein kinases, which play crucial roles in various cellular processes, including cell growth, differentiation, and metabolism. The compound has been studied in the context of various diseases, particularly cancer, due to its ability to modulate signaling pathways that are often dysregulated in tumorigenesis. GSK1838705A exhibits specific binding affinity to its target kinases, which contributes to its efficacy and selectivity. In terms of physical properties, detailed solubility, stability, and pharmacokinetic profiles are typically assessed during drug development, although specific values may vary based on formulation and testing conditions. Overall, GSK1838705A represents a promising candidate in the field of medicinal chemistry, particularly in the development of targeted therapies.

2-[[2-[[1-[2-(Dimethylamino)acetyl]-2,3-dihydro-5-methoxy-1H-indol-6-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-6-fluoro-N-methylbenzamide

<p>GSK1838705A: IGF-1R inhibitor (IC50=2.0nM), IR (1.6nM), ALK (0.5nM), minimal other kinase impact.</p>

CAS 1116235-97-2

GSK1838705A

2-[[2-[[1-[2-(Dimethylamino)acetyl]-2,3-dihydro-5-methoxy-1H-indol-6-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-6-fluoro-N-methylbenzamide

Ref: IN-DA003A9W

GSK1838705A

Ref: 54-BUP03608

GSK1838705A

Ref: TM-T3079